Lipocine News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.12.24	Lipocine's LPCN 1148 Gets Fast Track Status To Treat Sarcopenia In Decompensated Cirrhosis Patients (RTTNews)
08.10.24	Lipocine Inks Distribution Deal With Pharmalink To Commercialize TLANDO In GCC Countries (RTTNews)
25.06.24	Lipocine: LPCN 1154 Meets Standard Bioequivalence Criteria In Pivotal Pharmacokinetic Study (RTTNews)
11.04.24	Lipocine Reports Positive Phase 2 Results For LPCN 2401 In Participants With Obesity (RTTNews)
28.03.24	Lipocine: LPCN 1148 Meets Primary And Hepatic Encephalopathy Endpoints In Phase 2 Study (RTTNews)
18.01.24	Lipocine Signs TLANDO Franchise License Deal With Verity Pharma (RTTNews)
06.06.23	Pre-market Movers: FRZA, GTLB, GGE, CDRE, ZURA… (RTTNews)
15.09.22	Lipocine Announces Favorable Regulatory Pathway On LPCN 1154 For Post-Partum Depression (RTTNews)
11.07.22	Lipocine Says FDA Oks LPCN 2101 IND For Adult Epilepsy Treatment (RTTNews)
28.02.22	Biotech Stocks Facing FDA Decision In March 2022 (RTTNews)
28.09.21	Lipocine Says FDA Affirms Class 1 NDA Resubmission For TLANDO - Quick Facts (RTTNews)
25.08.21	Lipocine: Positive Topline Results Support LPCN 1144 Development For Regulatory Approval (RTTNews)
05.08.21	Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2021 (PR Newswire)
06.07.21	Lipocine To Present At The Ladenburg Thalmann Healthcare Conference (PR Newswire)
23.06.21	Lipocine Announces Presentations at The International Liver Congress™ 2021 Digital Event (PR Newswire)
16.06.21	Lipocine To Present At The Raymond James Human Health Innovation Conference (PR Newswire)
14.06.21	Lipocine Says FDA Clears IND Application To Initiate Phase 2 Study For LPCN 1154 - Quick Facts (RTTNews)
26.05.21	Clarus Wins Patent Infringement Lawsuit Brought By Lipocine On JATENZO (RTTNews)
21.01.21	Pre-market Movers In Healthcare Sector: ADXN, CLSN, CLBS, JAGX, ECOR, ADMP… (RTTNews)
12.01.21	Lipocine Reports Positive Topline Phase 2 Results From LPCN 1144 LiFT Study; Stock Rises (RTTNews)
30.12.20	Lipocine Enrolling Patients Into Open Label Extension To LPCN 1144 Phase 2 LiFT Study (RTTNews)
29.12.20	Lipocine : U.S. Court Postpones Clarus Patent Litigation Trial Scheduled (RTTNews)
09.12.20	Pre-market Movers In Healthcare Sector: RCKT, LPCN, PRPH, KZIA, CRIS… (RTTNews)
09.12.20	FDA Finally Gives Tentative Approval To Lipocine's Oral Testosterone Replacement Therapy (RTTNews)
07.12.20	Week Ahead In Pharma: FDA Decisions, ASH Data Readouts (LPCN, SYRS, MBIO, CYAD...) (RTTNews)
23.11.20	Pre-market Movers In Healthcare Sector: EIGR, SNOA, REGN, TTNP, OCGN… (RTTNews)
24.09.20	Pre-market Movers In Healthcare Sector: BIOL, OTIC, ANPC, CEMI, LPCN, NAOV... (RTTNews)
22.09.20	ABIO Joins Battle Against COVID-19, ERYP On Watch, LPCN To Report NASH Study Results In Q1 (RTTNews)
21.09.20	Pre-market Movers In Healthcare Sector: ONTX, ACST, VXRT, CMPS, LPCN... (RTTNews)
15.09.20	Pre-market Movers In Healthcare Sector: NVUS, MRNS, ABIO, LPCN, CLRB, VXRT… (RTTNews)
03.09.20	Pre-market Movers In Healthcare Sector: SNSS, NNVC, STRO, FLGT, LPCN... (RTTNews)
31.08.20	Pre-market Movers In Healthcare Sector: AIMT, HUGE, AMRN, EVFM, LPCN... (RTTNews)
27.08.20	Pre-market Movers In Healthcare Sector: EYPT, CLVS, ABT, VBIV, LPCN... (RTTNews)
26.08.20	Pre-market Movers In Healthcare Sector: FLDM, IMUX, LPCN, SRNE, ZSAN… (RTTNews)
17.08.20	Pre-market Movers In Healthcare Sector: CLRB, SNOA, PRNB, LPCN, TLC... (RTTNews)
27.07.20	Biotech Stocks Facing FDA Decision In August 2020 (RTTNews)
05.03.20	Lipocine: It's All About Tlando, NASH & Patent Trial (RTTNews)
25.02.20	COCP, MRNA Jump On Coronavirus Update, LPCN Making 4th Try, NGM Up On NASH Data (RTTNews)
12.11.19	ASLN Slumps As TreeTopp Flops, CSTL On Watch, KDMN Rocks, NXTC Down 53% (RTTNews)
11.11.19	FDA Rejects Lipocine's TLANDO Yet Again (RTTNews)
11.11.19	Lipocine Receives Complete Response Letter From FDA For TLANDO - Quick Facts (RTTNews)
11.11.19	LPCN Awaits FDA Word, NKTR On Track, All's Well With Five Prime's FPT155 (RTTNews)
28.10.19	Biotech Stocks Facing FDA Decision In November 2019 (RTTNews)
18.01.19	6 Top Gainers In Healthcare Sector (BIOC, AGEN, LPCN...) (RTTNews)
25.10.18	CMTA Abuzz, EIDX To Report Data In Nov., All Eyes On OPHT (RTTNews)
07.06.18	Lipocine Announces Dosing in Ambulatory Blood Pressure Study for TLANDO™ (PR Newswire)
12.05.18	An Ear To The Pharma: 8 Stocks To Watch (VYGR, BOLD, RXII, CYAD…) (RTTNews)
10.05.18	FDA Snubs LPCN Again, NVTA Boosts Revenue Outlook, New Lease Of Life For VTVT (RTTNews)
07.05.18	Lipocine Announces Financial and Operational Results for the First Quarter Ended March 31, 2018 (PR Newswire)
28.04.18	Biotech Stocks Facing FDA Decision In May (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Roche Hldg G	255.50	0.75 %	K V
Nestle	74.88	0.62 %	K V
CieFinRichemont	137.90	0.40 %	K V
Swiss Life Hldg	699.60	0.32 %	K V
Swisscom	504.50	0.30 %	K V
Sika	215.80	-0.37 %	K V
Givaudan	3’966.00	-0.40 %	K V
Lonza Grp	535.80	-0.41 %	K V
Geberit	514.60	-0.46 %	K V
ABB	49.07	-0.95 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Lipocine Inc

Aktien Top/Flop

Meistgelesene Nachrichten